Anti-inflammatory use during surgery could improve cancer outcomes
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read more
The world’s first clinical trial (SURGUVANT) evaluating anti-inflammatory use at the time of surgery in colon cancer patients to improve
Read moreA new study led by the Spanish National Cancer Research Centre (CNIO) reveals that up to 20% of genes classified
Read moreScientists have discovered a link between certain genetic mutations, the aggressiveness of prostate cancer, risk of developing the disease and
Read moreThe rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and
Read moreThe previous decade has seen dramatic advances in the treatment of non-small cell lung cancer, as genes driving subtypes of
Read moreGame theory can be utilized to identify potential flaws in current cancer treatment approaches and suggest new strategies to improve
Read moreA new study published in the Journal of the National Cancer Institute has identified specific genes associated with increased risk
Read moreAs treatment for early stage breast cancer becomes less extensive and more precise, a new concern is surfacing: Cancer takes
Read moreA new molecule designed by University of Adelaide researchers shows great promise for future treatment of many cancers. The new
Read moreA class of molecules formed when the body metabolizes omega-3 fatty acids could inhibit cancer’s growth and spread, University of
Read more